Diaphragm used with Replens gel and risk of bacterial vaginosis: Results from a randomized controlled trial

Infectious Diseases in Obstetrics and Gynecology

Volumn 2012, Issue , 2012, Pages

  Cohen, Craig R ^a   Cheng, Su Chun ^a   Shiboski, Stephen ^a   Chipato, Tsungai ^b   Matu, Martin ^c,d   Mwangi, James ^c   Mutimutema, Monalisa E S ^b   Tuveson, Jennifer ^a   Kamba, Mavis ^b   Padian, Nancy ^e   Van Der Straten, Ariane ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d AMREF HEALTH AFRICA   (Kenya)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE; POLYCARBOPHIL; LIPID;

ADULT; ARTICLE; BACTERIAL STRAIN; CONDOM; CONTROLLED STUDY; FEMALE; FOLLOW UP; GEL; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; UTERINE CERVIX CAP; VAGINA SMEAR; VAGINITIS; ADOLESCENT; COHORT ANALYSIS; FEMALE CONTRACEPTIVE DEVICE; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SOUTH AFRICA; STATISTICS; VAGINA; ZIMBABWE;

ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SOUTH AFRICA; VAGINA; VAGINOSIS, BACTERIAL; ZIMBABWE;

EID: 84870205100     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2012/921519     Document Type: Article

References (28)

1. Cherpes T. L., Meyn L. A., Krohn M. A., Lurie J. G., Hillier S. L., Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clinical Infectious Diseases 2003 37 3 319 325 2-s2.0-0042160294 10.1086/375819 (Pubitemid 36976487)
2. Cohen C. R., Duerr A., Pruithithada N., Rugpao S., Hillier S., Garcia P., Nelson K., Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in chiang mai, thailand. AIDS 1995 9 9 1093 1097 2-s2.0-0029114640
3. Sewankambo N., Gray R. H., Wawer M. J., HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. The Lancet 1997 350 9093 546 550 2-s2.0-0031581573 (Pubitemid 27348430)
4. Cohen C. R., Lingappa J. R., Baeten J. M., Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Medicine 2012 9 6 e1001251
5. Bukusi E. A., Cohen C. R., Meier A. S., Waiyaki P. G., Nguti R., Njeri J. N., Holmes K. K., Bacterial vaginosis: risk factors among kenyan women and their male partners. Sexually Transmitted Diseases 2006 33 6 361 367 2-s2.0-33744808525 10.1097/01.olq.0000200551.07573.df (Pubitemid 43833023)
6. 2-generating lactobacilli. Journal of Infectious Diseases 1991 164 1 94 100 2-s2.0-0025996165
7. Hashemi F. B., Ghassemi M., Faro S., Aroutcheva A., Spear G. T., Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. Journal of Infectious Diseases 2000 181 5 1574 1580 2-s2.0-0034091550 10.1086/315455 (Pubitemid 30387747)
8. Hashemi F. B., Ghassemi M., Roebuck K. A., Spear G. T., Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. Journal of Infectious Diseases 1999 179 4 924 930 2-s2.0-0032925356 10.1086/314674 (Pubitemid 29159338)
9. Rebbapragada A., Howe K., Wachihi C., Pettengell C., Sunderji S., Huibner S., Ball T. B., Plummer F. A., Jaoko W., Kaul R., Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. Journal of Acquired Immune Deficiency Syndromes 2008 49 5 520 522 2-s2.0-62749093768 10.1097/QAI.0b013e318189a7ca
10. Bolton M., van der Straten A., Cohen C. R., Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sexually Transmitted Diseases 2008 35 3 214 225 2-s2.0-42949116840 10.1097/OLQ.0b013e31815b017a (Pubitemid 351619515)
11. Sobel J., Peipert J. F., McGregor J. A., Livengood C., Martin M., Robbins J., Wajszczuk C. P., Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology 2001 9 1 9 15 2-s2.0-0034980511 (Pubitemid 32510019)
12. Sobel J. D., Chaim W., Thomason J., Livengood C., Sweet R., McGregor J. A., Eschenbach D., Hillier S., Galask R., Faro S., Shangle E., Baker D., Comparative study of intravaginal metronidazole and triple-sulfa therapy for bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology 1996 4 2 66 70 (Pubitemid 26372820)
13. Sobel J. D., Schmitt C., Meriwether C., Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. Journal of Infectious Diseases 1993 167 3 783 784 2-s2.0-0027500313 (Pubitemid 23056363)
14. Wawer M. J., Gray R. H., Sewankambo N. K., Serwadda D., Paxton L., Berkley S., McNairn D., Wabwire-Mangen F., Li C., Nalugoda F., Kiwanuka N., Lutalo T., Brookmeyer R., Kelly R., Quinn T. C., A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, rakai, uganda. AIDS 1998 12 10 1211 1225 2-s2.0-7144226601 10.1097/00002030-199810000- 00014 (Pubitemid 28302424)
15. Gupta K., Hillier S. L., Hooton T. M., Roberts P. L., Stamm W. E., Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. Journal of Infectious Diseases 2000 181 2 595 601 2-s2.0-0034048827 10.1086/315267 (Pubitemid 30131827)
16. Hooton T. M., Roberts P. L., Stamm W. E., Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clinical Infectious Diseases 1994 19 2 274 278 2-s2.0-0028024046 (Pubitemid 24258926)
17. van De Wijgert J., Fullem A., Kelly C., Mehendale S., Rugpao S., Kumwenda N., Chirenje Z., Joshi S., Taha T., Padian N., Bollinger R., Nelson K., Phase 1 trial of the topical microbicide buffergel: safety results from four international sites. Journal of Acquired Immune Deficiency Syndromes 2001 26 1 21 27 2-s2.0-0035144537 (Pubitemid 32115047)
18. Milani M., Barcellona E., Agnello A., Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. European Journal of Obstetrics Gynecology and Reproductive Biology 2003 109 1 67 71 2-s2.0-0038685843 10.1016/S0301-2115(02)00478-5 (Pubitemid 36724644)
19. Padian N. S., van der Straten A., Ramjee G., Chipato T., de Bruyn G., Blanchard K., Shiboski S., Montgomery E. T., Fancher H., Cheng H., Rosenblum M., van der Laan M., Jewell N., McIntyre J., Diaphragm and lubricant gel for prevention of HIV acquisition in southern african women: a randomised controlled trial. The Lancet 2007 370 9583 251 261 2-s2.0-34447527138 10.1016/S0140- 6736(07)60950-7 (Pubitemid 47069513)
20. Nugent R. P., Krohn M. A., Hillier S. L., Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology 1991 29 2 297 301 2-s2.0-0026088584
21. van der Straten A., Shiboski S., Montgomery E. T., Moore J., De Bruyn G., Ramjee G., Chidanyika A., Kacanek D., Padian N., Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-saharan africa: a trajectory analysis. Journal of Acquired Immune Deficiency Syndromes 2009 50 4 419 426 2-s2.0-64249151384 10.1097/QAI.0b013e3181958511
22. van der Straten A., Cheng H., Moore J., Kacanek D., Blanchard K., De Bruyn G., Ramjee G., Chipato T., Montgomery E. T., Padian N., The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS and Behavior 2009 13 3 564 572 2-s2.0-67349255744 10.1007/s10461-008-9504-z
23. Sánchez J., Campos P. E., Courtois B., Gutierrez L., Carrillo C., Alarcon J., Gotuzzo E., Hughes J., Watts D., Hillier S. L., Buchanan K., Holmes K. K., Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sexually Transmitted Diseases 2003 30 4 273 279 2-s2.0-0344608886 10.1097/00007435-200304000-00001 (Pubitemid 36397825)
24. Sanchez S., Garcia P. J., Thomas K. K., Catlin M., Holmes K. K., Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2004 191 6 1898 1906 2-s2.0-10044276714 10.1016/j.ajog.2004.06.089 (Pubitemid 39601492)
25. van der Straten A., Napierala S., Cheng H., Mauck C., Depineres T., Dhlakama P., Thompson M., Chipato T., Hammond N., Padian N., A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in zimbabwe. Contraception 2007 76 5 389 399 2-s2.0-35349019753 10.1016/j.contraception.2007.07.004 (Pubitemid 47600126)
26. Soboll G., Schaefer T. M., Wira C. R., Effect of toll-like receptor (TLR) agonists on TLR and microbicide expression in uterine and vaginal tissues of the mouse. American Journal of Reproductive Immunology 2006 55 6 434 446 2-s2.0-33646241763 10.1111/j.1600-0897.2006.00381.x
27. Witkin S. S., Linhares I. M., Giraldo P., Bacterial flora of the female genital tract: function and immune regulation. Best Practice and Research 2007 21 3 347 354 2-s2.0-34249739205 10.1016/j.bpobgyn.2006.12.004 (Pubitemid 46825481)
28. Molteni B., D'Antuono A., Bandini P., Sintini G., Barcellona E., Agnello A., Milani M., Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections. Current Medical Research and Opinion 2004 20 6 849 853 2-s2.0-3042528686 10.1185/030079904125003692 (Pubitemid 38821522)